Drugs / GNS651
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04333914 | Apr 2020 → Jul 2021 | COVID-19 | Centre Leon Berard | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GNS651 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04333914 ↗ |
| Route | Oral | “200mg q.d. orally” NCT04333914 ↗ |